APYX vs MCD · rev $48.1M vs P/E 23, rev $25.92B
Apyx Medical Inc (APYX) versus McDonald’s Corporation (MCD) — a side-by-side from cached financials, not a winner call.
Apyx Medical Inc (APYX) is a medical devices company listed on US.
McDonald’s Corporation (MCD) is a restaurants company listed on NYSE. It is led by Chris Kempczinski.
Latest reported APYX revenue for 2024-12-31 was $48.1M. Net income was -$23.6M. Revenue was down 8.1% from 2023-12-31 to 2024-12-31. APYX currently screens at market cap $179.6M.
Latest reported MCD revenue for 2024-12-31 was $25.92B. Net income was $8.22B. Revenue was up 1.7% from 2023-12-31 to 2024-12-31. MCD currently screens at market cap $201.66B and trailing P/E 23.4.
APYX currently screens at market cap $179.6M. MCD currently screens at market cap $201.66B and trailing P/E 23.4.
Not investment advice. Open the APYX and MCD stock pages for the full models.
Not investment advice.